Chronic Stable Angina Pectoris

Disease-a-Month

Volumn 54, Issue 9, 2008, Pages 671-689

  Jawad, Evyan ^a   Arora, Rohit ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; ANTIANGINA PECTORIS AGENT; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BOSENTAN; CALCIUM ANTAGONIST; CALCIUM CHANNEL BLOCKING AGENT; DIPYRIDAMOLE; DOBUTAMINE; FASUDIL; GLYCERYL TRINITRATE; ISOSORBIDE MONONITRATE; IVABRADINE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; NICORANDIL; NIFEDIPINE; NITRATE; PERHEXILINE; PLACEBO; RANOLAZINE; TEBOROXIME TC 99M; TECHNETIUM 99M; TECHNETIUM DERIVATIVE; TESTOSTERONE; TETROFOSMIN TC 99M; THALLIUM; THALLIUM 201; TRIMETAZIDINE;

ANGINA PECTORIS; ANGIOCARDIOGRAPHY; BLOOD PRESSURE; BRADYCARDIA; BRONCHOSPASM; CENTRAL NERVOUS SYSTEM DISEASE; CHRONIC DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; CONSTIPATION; CORONARY ARTERY DISEASE; COUNTERPULSATION; DIAGNOSTIC PROCEDURE; DIAGNOSTIC TEST; DISEASE CLASSIFICATION; DISEASE DURATION; DISEASE EXACERBATION; DISEASE SEVERITY; DIZZINESS; DRUG BLOOD LEVEL; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG HALF LIFE; DRUG MECHANISM; DRUG METABOLISM; DRUG RELEASE; ELECTROCARDIOGRAPHY; EXERCISE TEST; FATIGUE; FLUSHING; FOOT EDEMA; HEADACHE; HEART BLOCK; HEART FAILURE; HEART MUSCLE CONDUCTION DISTURBANCE; HEART MUSCLE ISCHEMIA; HEART MUSCLE OXYGEN CONSUMPTION; HEART MUSCLE REVASCULARIZATION; HEART REINFARCTION; HEART SCINTISCANNING; HEART SOUND; HUMAN; HYPERTENSION; IMPOTENCE; ISCHEMIC HEART DISEASE; LIVER TOXICITY; NONHUMAN; PATHOPHYSIOLOGY; PERIPHERAL NEUROPATHY; PERIPHERAL VASCULAR DISEASE; PHYSICAL EXAMINATION; POSITRON EMISSION TOMOGRAPHY; PRINZMETAL ANGINA PECTORIS; PROGNOSIS; QT INTERVAL; REVIEW; RISK FACTOR; SIDE EFFECT; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SPINAL CORD STIMULATION; ST SEGMENT DEPRESSION; STABLE ANGINA PECTORIS; STRESS ECHOCARDIOGRAPHY; SURVIVAL RATE; TACHYCARDIA; UNSPECIFIED SIDE EFFECT;

1-(5-ISOQUINOLINESULFONYL)-2-METHYLPIPERAZINE; ACETANILIDES; ANGINA PECTORIS; ANTIHYPERTENSIVE AGENTS; BENZAZEPINES; CHRONIC DISEASE; COUNTERPULSATION; CYCLIC NUCLEOTIDE-GATED CATION CHANNELS; EXERCISE TEST; HEART MURMURS; HUMANS; MYOCARDIAL CONTRACTION; MYOCARDIAL ISCHEMIA; MYOCARDIAL REVASCULARIZATION; MYOCARDIUM; NICORANDIL; OXYGEN CONSUMPTION; PERHEXILINE; PIPERAZINES; PROTEIN KINASE INHIBITORS; SULFONAMIDES; TRIMETAZIDINE; VASODILATOR AGENTS;

EID: 49749131632     PISSN: 00115029     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.disamonth.2008.06.009     Document Type: Review

References (39)

1. Foreman R.D. Mechanisms of cardiac pain. Annu Rev Physiol 61 (1999) 143-167
2. Benson C.J., Eckert S.P., and McCleskey E.W. Acid-evoked currents in cardiac sensory neurons: a possible mediator of myocardial ischemic sensation. Circ Res 84 8 (1999) 921-928
3. Crea F., Gaspardone A., and Kaski J.C. Relation between stimulation site of cardiac afferent nerves by adenosine and distribution of cardiac pain: results of a study in patients with stable angina. Am Coll Cardiol 20 7 (1992) 1498-1502
4. Halcox J.P., Schenke W.H., Zalos G., et al. Prognostic value of coronary vascular endothelial dysfunction. Circulation 106 (2002) 653-658
5. Reis S.E., Holubkov R., Conrad Smith A.J., et al. Coronary microvascular dysfunction is highly prevalent in women with chest pain in the absence of coronary artery disease: results from the NHLBI WISE study. Am Heart J 141 (2001) 735-741
6. Goldberg A.D., Becker L.C., Bonsall R., et al. Ischemic, hemodynamic, and neurohormonal responses to mental and exercise stress. Experience from the Psychophysiological Investigations of Myocardial Ischemia Study (PIMI). Circulation 94 10 (1996) 2402-2409
7. Ganz P., Abben R.P., and Barry W.H. Dynamic variations in resistance of coronary arterial narrowings in angina pectoris at rest. Am J Cardiol 59 1 (1987) 66-70
8. Juneau M., Johnstone M., Dempsey E., et al. Exercise-induced myocardial ischemia in a cold environment. Effect of antianginal medications. Circulation 79 5 (1989) 1015-1020
9. Henrikson C.A., Howell E.E., Bush D.E., et al. Chest pain relief by nitroglycerin does not predict active coronary artery disease. Ann Intern Med 139 12 (2003) 979-986
10. Sangareddi V., Chockalingam A., Gnanavelu G., et al. Canadian Cardiovascular Society classification of effort angina: an angiographic correlation. Coron Artery Dis 15 (2004) 111-114
11. Lee T.H., and Boucher C.A. Clinical practice. Noninvasive tests in patients with stable coronary artery disease. N Engl J Med 344 (2001) 1840-1845
12. Gibbons R.J., Chatterjee K., Daley J., et al. ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 33 (1999) 2092-2197 [Erratum in J Am Coll Cardiol 1999;34:314.]
13. Froelicher V.F., Lehmann K.G., Thomas R., et al. The electrocardiographic exercise test in a population with reduced workup bias: diagnostic performance, computerized interpretation, and multivariable prediction. Ann Intern Med 128 (1998) 965-974
14. Mark D.B., Shaw L., Harrell Jr. F.E., et al. Prognostic value of a treadmill exercise score in outpatients with suspected coronary artery disease. N Engl J Med 325 (1991) 849-853
15. Morise A.P., and Diamond G.A. Comparison of the sensitivity and specificity of exercise electrocardiography in biased and unbiased populations of men and women. Am Heart J 130 4 (1995) 741-747
16. Mieres J.H., Shaw L.J., Hendel R.C., et al. American Society of Nuclear Cardiology consensus statement: Task Force on Women and Coronary Artery Disease: the role of myocardial perfusion imaging in the clinical evaluation of coronary artery disease in women [correction]. J Nucl Cardiol 10 1 (2003) 95-101
17. Kwok Y., Kim C., Grady D., et al. Meta-analysis of exercise testing to detect coronary artery disease in women. Am J Cardiol 83 5 (1999) 660-666
18. Rodgers G.P., Ayanian J.Z., Balady G., et al. American College of Cardiology/American Heart Association clinical competence statement on stress testing: a report of the American College of Cardiology/American Heart Association/American College of Physicians-American Society of Internal Medicine Task Force on Clinical Competence. Circulation 102 (2000) 1726-1738
19. Dilsizian V., Rocco T.P., Freedman N.M.T., et al. Enhanced detection of ischemic but viable myocardium by the reinjection of thallium after stress-redistribution imaging. N Engl J Med 323 (1990) 141-146
20. Hachamovitch R., Berman D.S., Kiat H., et al. Exercise myocardial perfusion SPECT in patients without known coronary artery disease: incremental prognostic value and use in risk stratification. Circulation 93 (1996) 905-914
21. Smanio P.E., Watson D.D., Segalla D.L., et al. Value of gating of technetium-99m sestamibi single-photon emission computed tomographic imaging. J Am Coll Cardiol 30 (1997) 1687-1692
22. Schoenhagen P., Ziada R.M., Kapadia S.P., et al. Extent and direction of arterial remodeling in stable versus unstable coronary syndromes: an intravascular ultrasound study. Circulation 101 (2000) 598-603
23. Teo K.K., Yusuf S., and Furberg C.D. Effects of prophylactic antiarrhythmic drug therapy in acute myocardial infarction. An overview of results from randomized controlled trials. JAMA 270 13 (1993) 1589-1595
24. The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 288 (2002) 2981-2997 [Erratum in JAMA 2003;289:178, 2004;291:2196.]
25. Turnbull F. Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomized trials. Lancet 362 (2003) 1527-1535
26. Timmis A.D., Chaitman B.R., and Crager M. Effects of ranolazine on exercise tolerance and HbA1c in patients with chronic angina and diabetes. Eur Heart J 27 1 (2006) 42-48
27. Rosano G.M., Marazzi G., Patrizi R., et al. Comparison of trimetazidine plus sildenafil to chronic nitrates in the control of myocardial ischemia during sexual activity in patients with coronary artery disease. Am J Cardiol 95 3 (2005) 327-331
28. White H.D., and Lowe J.B. Antianginal efficacy of perhexiline maleate in patients refractory to beta-adrenoreceptor blockade. Int J Cardiol 3 2 (1983) 145-155
29. Lee L., Horowitz J., and Frenneaux M. Metabolic manipulation in ischaemic heart disease, a novel approach to treatment. Eur Heart J 25 8 (2004) 634-641
30. Effect of nicorandil on coronary events in patients with stable angina: the Impact Of Nicorandil in Angina (IONA) randomised trial. Lancet 359 9314 (2002) 1269-1275
31. Kinlay S., Behrendt D., Wainstein M., et al. Role of endothelin-1 in the active constriction of human atherosclerotic coronary arteries. Circulation 104 10 (2001) 1114-1118
32. Kyriakides Z.S., Kremastinos D.T., Kolettis T.M., et al. Acute endothelin-A receptor antagonism prevents normal reduction of myocardial ischemia on repeated balloon inflations during angioplasty. Circulation 102 16 (2000) 1937-1943
33. Borer J.S., Fox K., Jaillon P., et al. Antianginal and antiischemic effects of ivabradine, an I(f) inhibitor, in stable angina: a randomized, double-blind, multicentered, placebo-controlled trial. Circulation 107 6 (2003) 817-823
34. Tardif J.C., Ford I., Tendera M., et al. Efficacy of ivabradine, a new selective I (f) inhibitor, compared with atenolol in patients with chronic stable angina. Eur Heart J 26 23 (2005) 2529-2536
35. Mohri M., Shimokawa H., Hirakawa Y., et al. A Rho-kinase inhibition with intracoronary fasudil prevents myocardial ischemia in patients with coronary microvascular spasm. J Am Coll Cardiol 41 1 (2003) 15-19
36. Vicari R.M., Chaitman B., Keefe D., et al. Efficacy and safety of fasudil in patients with stable angina: a double-blind, placebo-controlled, phase 2 trial. J Am Coll Cardiol 46 10 (2005) 1803-1811
37. English K.M., Steeds R.P., Jones T.H., et al. Low-dose transdermal testosterone therapy improves angina threshold in men with chronic stable angina: a randomized, double-blind, placebo-controlled study. Circulation 102 16 (2000) 1906-1911
38. Foreman R.D., Linderoth B., Ardell J.L., et al. Modulation of intrinsic cardiac neurons by spinal cord stimulation: implications for its therapeutic use in angina pectoris. Cardiovasc Res 47 2 (2000) 367-375
39. Horvath K.A., Smith W.J., Laurence R.G., et al. Recovery and viability of an acute myocardial infarct after transmyocardial laser revascularization. J Am Coll Cardiol 25 1 (1995) 258-263